MaxCyte, Inc.
MXCT
$2.61
$0.062.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.06M | -35.74M | -35.43M | -36.57M | -37.92M |
| Total Depreciation and Amortization | 4.32M | 4.36M | 4.38M | 4.32M | 4.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.88M | 8.83M | 8.14M | 7.88M | 8.25M |
| Change in Net Operating Assets | -751.00K | 3.74M | 259.00K | -3.55M | 3.82M |
| Cash from Operations | -27.61M | -18.81M | -22.66M | -27.93M | -21.69M |
| Capital Expenditure | -1.65M | -2.42M | -2.73M | -2.95M | -3.70M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 9.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.58M | 6.88M | 6.40M | 13.90M | 58.68M |
| Cash from Investing | 6.93M | 4.46M | 3.66M | 10.95M | 54.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.06M | 2.14M | 1.95M | 1.39M | 2.14M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.06M | 2.14M | 1.95M | 1.39M | 2.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.62M | -12.21M | -17.05M | -15.59M | 35.44M |